ABPI proposes ‘Voluntary Scheme for Pricing, Access and Growth’ to support NHS and economic growth
The Association of the British Pharmaceutical Industry (ABPI) has proposed a Voluntary Scheme for Pricing, Access and Growth (VPAG)Â that aims to deliver a sustainable...
 ABPI President Pinder Sahota resignsÂ
The Association of the British Pharmaceutical Industry (ABPI) has announced that Pinder Sahota has decided to step down as President of the ABPI.
ABPI stated...
ABPI urges govt to scrap hike in repayment rate for drugmakers
The Association of the British Pharmaceutical Industry (ABPI) on Thursday (February 2) called for the government to scrap its plans to raise the repayment...
Collaboration between industry, NHS can improve equality of access to innovative medicines, reveals report
The NHS Confederation and the Association of the British Pharmaceutical Industry (ABPI) has published a report that demonstrated the importance of the collaboration between...
AbbVie, Eli Lilly exit UK drug pricing deal
Pharmaceutical companies AbbVie and Eli Lilly have withdrawn from Britain's voluntary medicines pricing agreement, an industry body said on Monday.
Companies are increasingly arguing that...
Moderna joins ABPI; aims to strengthen its footprint in UK
Moderna has joined one of the UK’s leading pharmaceutical industry body, Association of the British Pharmaceutical Industry (ABPI) to expand its footprint and investment...